Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch National Grid (NG.) by James Beard in The Motley Fool
- Hold Metals Exploration (MTL) by Steve Moore in ShareProphets
- Watch Gooch & Housego (GHH) by Steve Moore in ShareProphets
- Hold Lloyds Banking Group (LLOY) by Alan Oscroft in The Motley Fool
- Avoid The Mission Group (TMG) by Steve Moore in ShareProphets
- Avoid Tasty (TAST) by Steve Moore in ShareProphets
- Add M&G (MNG) by Harvey Jones in The Motley Fool
- Sell Victoria (VCP) by Tom Winnifrith in ShareProphets
- Sell Argo Group Ltd. (ARGO) by Tom Winnifrith in ShareProphets
- Hold Vistry Group (VTY) by Berenberg
- Buy Wise Class A (WISE) by UBS
- Buy Indivior (INDV) by Jefferies
- Buy Weir Group (WEIR) by Robert Stephens (Telegraph) in The Telegraph - Questor
- Buy Elementis (ELM) by Berenberg
- Buy Griffin Mining Ltd. (GFM) by Berenberg
- Speculative Buy The Mission Group (TMG) by Canaccord Genuity
- Buy Primary Health Properties (PHP) by Jonathan Price in ShareProphets
- Avoid Seeing Machines Ltd. NPV (DI) (SEE) by Steve Moore in ShareProphets
- Avoid DG Innovate (DGI) by Steve Moore in ShareProphets
- Buy Zotefoams (ZTF) by Steve Moore in ShareProphets
Avacta Group (AVCT) Share Price
Health Care Sector
NOTE: This is based on 61 open tips for Avacta Group (AVCT)
| Latest Bid : 51.00p | Latest Ask : 53.00p |
| High Today : 53.00p | Low Today : 51.00p |
| This Years High : 116.00p | This Years Low : 39.75p |
| Volume : 489,180 | MKT Cap : £191.88M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000
Avacta Group (AVCT) Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.Avacta Group (AVCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Lucian Miers | Premium Only | 2024-12-27 10:05:00 27/12/2024 | -8.33% |
| Sell | Tom Winnifrith | Premium Only | 2024-12-12 13:30:00 12/12/2024 | -20.93% |
| Hold | Deutsche Bank | Premium Only | 2024-12-10 07:30:00 10/12/2024 | 14.92% |
| Sell | Tom Winnifrith | Premium Only | 2024-09-17 10:35:00 17/09/2024 | 8.77% |
| Sell | Deutsche Bank | Premium Only | 2024-09-17 07:27:00 17/09/2024 | 33.46% |
Avacta Group (AVCT) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| GSA Capital Partners LLP | 0.78% | 10/07/2024 |
| Latest Bid : 51.00p | Latest Ask : 53.00p |
| High Today : 53.00p | Low Today : 51.00p |
| This Years High : 116.00p | This Years Low : 39.75p |
| Volume : 489,180 | MKT Cap : £191.88M |
Avacta Group Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Avacta Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Lucian Miers | Premium Only | 2024-12-27 10:05:00 27/12/2024 | -8.33% |
| Sell | Tom Winnifrith | Premium Only | 2024-12-12 13:30:00 12/12/2024 | -20.93% |
| Hold | Deutsche Bank | Premium Only | 2024-12-10 07:30:00 10/12/2024 | 14.92% |
| Sell | Tom Winnifrith | Premium Only | 2024-09-17 10:35:00 17/09/2024 | 8.77% |
| Sell | Deutsche Bank | Premium Only | 2024-09-17 07:27:00 17/09/2024 | 33.46% |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000